United Orthopedic (4129) — Capital Reinvestment Ratio

Latest as of December 2025: 1.13x

United Orthopedic (4129) has a Capital Reinvestment Ratio of 1.13x as of December 2025, meaning it reinvests 1% of its operating cash flow (NT$223.65 Million) in capital expenditures (NT$252.00 Million). See 4129 equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

1.13x
Capex / Operating Cash Flow

Operating Cash Flow

NT$223.65 Million
TWD

Capital Expenditures

NT$252.00 Million
TWD

Data as of

Dec 2025
Most recent filing

United Orthopedic Capital Reinvestment Ratio (2015–2025)

This chart tracks United Orthopedic's Capital Reinvestment Ratio across 11 annual periods. Check 4129 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for United Orthopedic (2015–2025)

Year-by-year Capital Reinvestment Ratio for United Orthopedic from 2015 to 2025. For live market cap and broader valuation context, see United Orthopedic market capitalisation.

Year Reinvestment Ratio Operating CF (TWD) Capital Expenditures YoY Change
2025 0.74x NT$1.03 Billion NT$761.23 Million ▼ -9.7%
2024 0.82x NT$717.29 Million NT$589.33 Million ▼ -41.3%
2023 1.40x NT$398.43 Million NT$557.53 Million ▲ +23.5%
2022 1.13x NT$340.79 Million NT$386.21 Million ▲ +66.9%
2021 0.68x NT$334.64 Million NT$227.21 Million ▲ +41.1%
2020 0.48x NT$481.65 Million NT$231.79 Million ▼ -20.8%
2019 0.61x NT$492.45 Million NT$299.41 Million ▼ -98.0%
2018 31.12x NT$12.41 Million NT$386.17 Million ▼ -84.6%
2017 201.60x NT$2.90 Million NT$584.43 Million ▲ +9048.2%
2016 2.20x NT$179.03 Million NT$394.53 Million ▲ +167.9%
2015 0.82x NT$252.75 Million NT$207.93 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow